2012
DOI: 10.1016/j.bbrc.2012.03.065
|View full text |Cite
|
Sign up to set email alerts
|

Antimicrobial properties of analgesic kyotorphin peptides unraveled through atomic force microscopy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
15
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 21 publications
(15 citation statements)
references
References 23 publications
0
15
0
Order By: Relevance
“…Fosfomycin has the ability to penetrate into the fluid of the interstitial space of soft tissues (Frossard et al 2000) to reach levels sufficient to substantially inhibit the growth of relevant bacteria at the target site. The pharmacokinetic and pharmacodynamic properties of fosfomycin facilitate design of drug doses with clinically relevant concentrations for sites such as lungs, bone, soft tissue, and serum and heart valves (Roussos et al 2009 (Eaton et al 2008), kyotorphin peptide (Ribeiro et al 2012), carvacrol (Storia et al 2011) on Staphylococcal aureus biofilms. The nanoscale visualization and characterization of Staphylococcus aureus cells (Ribeiro et al 2012) demonstrated that kyotorphin perturbed the bacterial cell-wall membrane by blebbing, lysis and disruption.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Fosfomycin has the ability to penetrate into the fluid of the interstitial space of soft tissues (Frossard et al 2000) to reach levels sufficient to substantially inhibit the growth of relevant bacteria at the target site. The pharmacokinetic and pharmacodynamic properties of fosfomycin facilitate design of drug doses with clinically relevant concentrations for sites such as lungs, bone, soft tissue, and serum and heart valves (Roussos et al 2009 (Eaton et al 2008), kyotorphin peptide (Ribeiro et al 2012), carvacrol (Storia et al 2011) on Staphylococcal aureus biofilms. The nanoscale visualization and characterization of Staphylococcus aureus cells (Ribeiro et al 2012) demonstrated that kyotorphin perturbed the bacterial cell-wall membrane by blebbing, lysis and disruption.…”
Section: Introductionmentioning
confidence: 99%
“…The pharmacokinetic and pharmacodynamic properties of fosfomycin facilitate design of drug doses with clinically relevant concentrations for sites such as lungs, bone, soft tissue, and serum and heart valves (Roussos et al 2009 (Eaton et al 2008), kyotorphin peptide (Ribeiro et al 2012), carvacrol (Storia et al 2011) on Staphylococcal aureus biofilms. The nanoscale visualization and characterization of Staphylococcus aureus cells (Ribeiro et al 2012) demonstrated that kyotorphin perturbed the bacterial cell-wall membrane by blebbing, lysis and disruption. The molecular mechanism of nanoconjugated vancomycin (Chakraborty et al 2012) towards antimicrobial therapeutic approaches in treating Staphylococcus aureus at the nanoscale proved that AFM is a potential tool in understanding the types of antimicrobial induced bacterial cell-wall damage.…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, previous studies showed that KTP derivatives were inactive against Gram-negative bacteria (Ribeiro et al 2012), but the results presented here suggest that these peptides can still act as anti-inflammatory and sepsis molecules (beyond analgesic) to target a variety of inflammatory and pain disorders. Although the KTP derivatives have been shown to bind LPS, further studies will be conducted to elucidate how they block the biological effects of LPS.…”
Section: Discussionmentioning
confidence: 86%
“…This shape is known as echinocyte and is reversible. Regardless these changes all derivatives were virtually not toxic to RBCs (Ribeiro et al, 2012). …”
Section: Ktp Derivatives Beyond Analgesiamentioning
confidence: 99%
“…KTP (net charge: +1), KTP-NH 2 (+2), IbKTP-NH 2 (+1) and IbKTP (0) were tested against Gram-negative Escherichia coli ( E. coli ) and Gram-positive Staphylococcus aureus ( S. aureus ). (Ribeiro et al, 2012). All derivatives were inactive against E. coli up to 100 μM but they were active against S. aureus , with the exception of KTP.…”
Section: Ktp Derivatives Beyond Analgesiamentioning
confidence: 99%